Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
| Errataetall: |
CommentOn: Mol Psychiatry. 2022 Apr;27(4):1898-1907. - PMID 34997196 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Molecular psychiatry - 27(2022), 9 vom: 06. Sept., Seite 3562 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khani, Elnaz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.12.2022 Date Revised 13.12.2023 published: Print-Electronic CommentOn: Mol Psychiatry. 2022 Apr;27(4):1898-1907. - PMID 34997196 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41380-022-01545-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339179112 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339179112 | ||
| 003 | DE-627 | ||
| 005 | 20231227130742.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41380-022-01545-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM339179112 | ||
| 035 | |a (NLM)35388182 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khani, Elnaz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2022 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Mol Psychiatry. 2022 Apr;27(4):1898-1907. - PMID 34997196 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Fluvoxamine |2 NLM | |
| 650 | 7 | |a O4L1XPO44W |2 NLM | |
| 650 | 7 | |a Receptors, sigma |2 NLM | |
| 700 | 1 | |a Entezari-Maleki, Taher |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular psychiatry |d 1997 |g 27(2022), 9 vom: 06. Sept., Seite 3562 |w (DE-627)NLM09062694X |x 1476-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2022 |g number:9 |g day:06 |g month:09 |g pages:3562 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41380-022-01545-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2022 |e 9 |b 06 |c 09 |h 3562 | ||